Co-delivery of doxorubicin and hydroxychloroquine via chitosan/alginate nanoparticles for blocking autophagy and enhancing chemotherapy in breast cancer therapy
Breast cancer (BC) is the most common malignancy in women worldwide, and the standard treatment is chemotherapy or radiotherapy after surgery. In order to reduce the side effects of chemotherapy, various nanoparticles (NPs) have been discovered and synthesized, which has become a promising treatment...
Main Authors: | Hui Zhang, Qingwen Xue, Zihan Zhou, Ningning He, Shangyong Li, Cheng Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1176232/full |
Similar Items
-
Autophagy Inhibition via Hydroxychloroquine or 3-Methyladenine Enhances Chemotherapy-Induced Apoptosis in Neuro-Blastoma and Glioblastoma
by: Darcy Wear, et al.
Published: (2023-07-01) -
Lymph cancer chemotherapy: delivery of doxorubicin-gemcitabine prodrug and vincristine by nanostructured lipid carriers
by: Ni S, et al.
Published: (2017-02-01) -
Application of chitosan/alginate nanoparticle in oral drug delivery systems: prospects and challenges
by: Shangyong Li, et al.
Published: (2022-12-01) -
Delineating the role of autophagy in driving the resistance to cancer chemotherapy
by: P A Shantanu, et al.
Published: (2021-01-01) -
Impact of autophagy on chemotherapy and radiotherapy mediated tumor cytotoxicity: "to live or not to live"
by: Xuehuo eZeng, et al.
Published: (2011-10-01)